Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitigation of Facial Irritation with Aczone and Retin-A Micro
NCT01313728Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Dec 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapsone in acne vulgaris, sponsored by Valeant Pharmaceuticals. Started Dec 2010; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01313728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313728.